Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/10725460

J. Immunol. Methods 2000 Apr 3 237 1-2 159-73

Download in:

View as

General Info

PMID
10725460